Skye Bioscience SKYE
NASDAQ SKYE
$1.63 +0.01 (+0.62%)
At close: Oct 21, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Receivables - Other (2021 - 2023)

Updated

Skye Bioscience's Receivables - Other was $50,000 in Q2 2023, unchanged from $50,000 a year earlier and unchanged from the prior quarter.

Analysis

Skye Bioscience (SKYE) Receivables - Other (2021 - 2023) Analysis & Trends

At the end of FY2021, Receivables - Other at Skye Bioscience came in at $13,432.

  • Compared with a year earlier, Receivables - Other was higher in three of the last four quarters, with growth averaging 104.0%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Skye Bioscience 7.90 Mn -80.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 50,000.00
Mar 31, 2023 50,000.00
Sep 30, 2022 50,000.00
Jun 30, 2022 50,000.00
Mar 31, 2022 48,908.00
Dec 31, 2021 13,432.00
Sep 30, 2021 18,125.00
Jun 30, 2021 14,805.00
API Access

Skye Bioscience Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=SKYE&period=max&api_key=YOUR_API_KEY